Project Number 1R44AG055184-01 Agency/Funding Organization NIA Funding Year 2016 View Full Project Details for 2-HYDROXYBENZYLAMINE FOR THE PREVENTION OF ALZHEIMER'S DISEASE: INITIAL EVALUATION IN HUMANS Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) g. Oxidative Stress Researcher and Organization Principal Investigator RATHMACHER, JOHN A Principal Investigator First Name JOHN Principal Investigator Last Name RATHMACHER Awardee Organization METABOLIC TECHNOLOGIES, INC. Awardee State Iowa Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-14-088: Direct Phase II SBIR Grants to Support Biomedical Technology Development FY Overall Cost $672,479 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Brain Penetrance of 2-HOBA in Humans 2-HOBA: Multiple Dosing Study in Healthy Humans 2-HOBA: Multiple Dosing Study in Older Adults 2-HOBA: Initial Evaluation in Humans
